What question did this study set out to answer?

This work aims to evaluate the differences in hemodynamic effects, pharmacokinetics, and electrophysiological actions of intravenous versus oral amiodarone.

April 18, 2026Journal of Cardiovascular Electrophysiology

Intravenous Amiodarone: Hemodynamics, Pharmacokinetics, Electrophysiology, and Clinical Utility

View Full Paper

Ask AI

Bookmark

Why the study?

Important differences exist between oral and intravenous amiodarone administration regarding hemodynamics, pharmacokinetics, electrophysiology, and antiarrhythmic efficacy.

What are the hemodynamic, pharmacokinetic, electrophysiological effects, and clinical utility of intravenous amiodarone compared to oral administration?

Population

Patients with supraventricular and ventricular arrhythmias, including life-threatening ventricular…

Comparison

Intravenous amiodarone vs Oral amiodarone

Design

Review

Authors

NMNelson D. MostowUniversity of Wisconsin–Madison TVT VrobelUniversity School DNDeborah NoonUniversity Hospitals of Cleveland

Discussion

Member takes

Implication

Mandates route-specific hemodynamic monitoring with amiodarone; challenges interchangeable use between oral and IV formulations in practice and research.

Key Points

This work aims to evaluate the differences in hemodynamic effects, pharmacokinetics, and electrophysiological actions of intravenous versus oral amiodarone.
Comparison of intravenous and oral amiodarone effects on systemic vascular resistance and contractility.
Evaluation of pharmacokinetic distribution in vivo during the initial days of therapy.
Assessment of electrophysiological effects at the sinus and atrioventricular nodes following administration.
Intravenous amiodarone causes decreased systemic vascular resistance and contractility, particularly in patients with impaired ventricular function.
Multicompartmental pharmacokinetics with significant tissue distribution observed during initial therapy.
Immediate electrophysiological effects noted, such as prolonged refractory periods in atrial and ventricular muscle.

Structured PICO

What are the hemodynamic, pharmacokinetic, electrophysiological effects, and clinical utility of intravenous amiodarone compared to oral administration?

Population

Patients with supraventricular and ventricular arrhythmias, including life-threatening ventricular tachycardia and ventricular fibrillation refractory to conventional agents

Intervention

Intravenous amiodarone

Comparator

Oral amiodarone

Outcome

Hemodynamic effects, pharmacokinetic distribution, electrophysiological actions, and antiarrhythmic efficacy

Intravenous amiodarone is a highly effective agent for refractory life-threatening arrhythmias, though its unique hemodynamic, pharmacokinetic, and electrophysiological properties require careful management in critical care settings.

Cite This Study

Mostow et al. (1986) studied this question.

synapsesocial.com/papers/69e3213840886becb6540661 https://doi.org/10.1111/j.1540-8167.1986.tb00011.x

View Full Paper

Ask AI

Bookmark

Implication

Mandates route-specific hemodynamic monitoring with amiodarone; challenges interchangeable use between oral and IV formulations in practice and research.

Intravenous Amiodarone: Hemodynamics, Pharmacokinetics, Electrophysiology, and Clinical Utility

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Intravenous Amiodarone: Hemodynamics, Pharmacokinetics, Electrophysiology, and Clinical Utility

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider